Search

Author/Creator Jarell, Abel

1. A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192G. Issue 45 (21st October 2020)

Authors:
Riddle, Mark S.; Maciel, Milton; Porter, Chad K.; Poole, Steven T.; Gutierrez, Ramiro L.; Gormley, Robert; Laird, Renee M.; Sebeny, Peter J.; Dori, Kathleen E.; Greenleaf, Melissa E.; Hoq, Fahmida; Turiansky, George W.; Jarell, Abel; Hawk, Douglas; Tribble, David; Savarino, Stephen J.
Journal:
Vaccine
Issue:
Volume 38:Issue 45(2020)
Page Start:
7040
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial. (1st June 2020)

Authors:
Blauvelt, A.; Papp, K.; Gottlieb, A.; Jarell, A.; Reich, K.; Maari, C.; Gordon, K.B.; Ferris, L.K.; Langley, R.G.; Tada, Y.; Lima, R.G.; Elmaraghy, H.; Gallo, G.; Renda, L.; Park, S.Y.; Burge, R.; Bagel, J.; Vender, Ronald; Lomaga, Mark A.; Delorme, Isabelle
Journal:
British journal of dermatology
Issue:
Volume 182:Number 6(2020)
Page Start:
1348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗